Safety/Immunogenicity/Genetic Drift of MP-12 Rift Valley Fever Vaccine

NCT00415051 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

U.S. Army Medical Research and Development Command